R&D
May, 2016
Phase I dose-escalation trial of Sym004, a mixture of two anti-EGFR antibodies, in Japanese patients with advanced solid tumors
Journal of Clinical Oncology 34, no. 15_suppl (May 2016) 2522-2522.
February 1, 2016
Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models
Clin Cancer Res. 2016 Feb 1;22(3):633-43
November 19, 2015
Novel antibody–antibiotic conjugate eliminates intracellular S. aureus.
Nature 527, 323–328 (2015)
November 19, 2015
Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
Nature 527, 323–328 (2015)
November 10, 2015
In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography
Oncotarget. 2015 Nov 10;6(35):37486-99
October 8, 2015
The genomic landscape of response to EGFR blockade in colorectal cancer
Nature. 2015 Oct 8;526(7572):263-7
September 25, 2015
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
Clin Cancer Res. 2015 Sep 15;21(18):4110-22.
July, 2015
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
Cancer Chemother Pharmacol. 2015 Jul;76(1):13-20